Summit Biosciences

Lexington, United States Founded: 2008 • Age: 18 yrs Acquired By Kindeva Drug Delivery
Nasal spray drug products are developed, manufactured, and commercialized.
Request Access

About Summit Biosciences

Summit Biosciences is a company based in Lexington (United States) founded in 2008 by Edwin Cohen was acquired by Kindeva Drug Delivery in January 2024.. Summit Biosciences operates in a competitive market with competitors including Gland Pharma, Exela Pharma, Luoxin Pharmaceutical Group, ApiJect and August Bioservices, among others.

  • Headquarter Lexington, United States
  • Founders Edwin Cohen
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Summit Biosciences
Headcount 10-50
Employee Profiles 18
Board Members and Advisors 4
Employee Profiles
People
Sonia L. Egbert
CFO
People
Ted A. Marcuccio
CBO
People
Erin Ashley
Quality Control Shift Lead
People
Gregory G. Plucinski
President & COO

Unlock access to complete

Board Members and Advisors
people
Richard D. Cohen
Chairman

Unlock access to complete

Funding Insights of Summit Biosciences

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Summit Biosciences

Summit Biosciences has secured backing from 1 investor. Prominent investors backing the company include Kindeva Drug Delivery. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Injectables and biologics products are manufactured by the CDMO.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Summit Biosciences

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Summit Biosciences

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Summit Biosciences Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Summit Biosciences

Summit Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gland Pharma, Exela Pharma, Luoxin Pharmaceutical Group, ApiJect and August Bioservices, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Generic injectable drugs are manufactured across therapeutic segments.
domain founded_year HQ Location
Sterile injectable pharmaceuticals are manufactured alongside CDMO services.
domain founded_year HQ Location
Developer and manufacturer of pharmaceutical products
domain founded_year HQ Location
Medicine injectors are manufactured by ApiJect for medical applications.
domain founded_year HQ Location
Diversified research services for clinical solutions are offered.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Summit Biosciences

Frequently Asked Questions about Summit Biosciences

When was Summit Biosciences founded?

Summit Biosciences was founded in 2008.

Where is Summit Biosciences located?

Summit Biosciences is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.

Who is the current CEO of Summit Biosciences?

Edwin Cohen is the current CEO of Summit Biosciences. They have also founded this company.

What does Summit Biosciences do?

Summit Biosciences was founded in 2008 in Lexington, United States, as a specialty pharmaceutical company. Generic and innovative nasal spray products are developed, manufactured, and commercialized by the firm. Contract development and manufacturing services are also provided to partners for various nasally delivered drugs and systems. The facility is FDA-approved, DEA-registered, and compliant with cGMP standards, supporting product development from concept through to commercialization.

Who are the top competitors of Summit Biosciences?

Summit Biosciences's top competitors include Exela Pharma, Gland Pharma and Luoxin Pharmaceutical Group.

Who are Summit Biosciences's investors?

Summit Biosciences has 1 investor. Key investors include Kindeva Drug Delivery.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available